{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:57Z","timestamp":1787020377139,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Judy and Fred Wilpon Family Foundation","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Baker Institute Internal grant","award":["dog3"],"award-info":[{"award-number":["dog3"]}]},{"name":"Cornell Research Animal Health grant","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19am0401013, JP19am0101078, JP19ae0101028"],"award-info":[{"award-number":["JP19am0401013, JP19am0101078, JP19ae0101028"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kyle\u2019s Legacy Inc","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Mr. Jake Holshuh","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"Mrs. Alice C. Sinclair","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"ClancysCure","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Canine visceral hemangiosarcoma (HSA) is a highly aggressive cancer of endothelial origin that closely resembles visceral angiosarcoma in humans, both clinically and histopathologically. Currently there is an unmet need for new diagnostics and therapies for both forms of this disease. The goal of this study was to utilize Chromatin run-on sequencing (ChRO-seq) and immunohistochemistry (IHC) to identify gene and protein expression signatures that may be important drivers of HSA progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>ChRO-seq was performed on tissue isolated from 17 HSA samples and 4 normal splenic samples. Computational analysis was then used to identify differentially expressed genes and these factors were subjected to gene ontology analysis. ChRO-seq analysis revealed over a thousand differentially expressed genes in HSA tissue compared with normal splenic tissue (FDR &lt;\u20090.005). Interestingly, the majority of genes overexpressed in HSA tumor tissue were associated with extracellular matrix (ECM) remodeling. This observation correlated well with our histological analysis, which found that HSA tumors contain a rich and complex collagen network. Additionally, we characterized the protein expression patterns of two highly overexpressed molecules identified in ChRO-seq analysis, podoplanin (PDPN) and laminin alpha 4 (LAMA4). We found that the expression of these two ECM-associated factors appeared to be largely limited to transformed endothelial cells within the HSA lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Outcomes from this study suggest that ECM remodeling plays an important role in HSA progression. Additionally, our study identified two potential novel biomarkers of HSA, PDPN and LAMA4. Interestingly, given that function-blocking anti-PDPN antibodies have shown anti-tumor effects in mouse models of canine melanoma, our studies raise the possibility that these types of therapeutic strategies could potentially be developed for treating canine HSA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12917-020-02395-3","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T06:02:55Z","timestamp":1592805775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-9371","authenticated-orcid":false,"given":"Chinatsu","family":"Mukai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunju","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Sams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Zu","family":"Klampen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Anguish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Choate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Pei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinari","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Danko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Coonrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"2395_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1136\/jclinpath-2017-204601","volume":"70","author":"E Shustef","year":"2017","unstructured":"Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol. 2017;70:917\u201325. https:\/\/doi.org\/10.1136\/jclinpath-2017-204601.","journal-title":"J Clin Pathol"},{"key":"2395_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","volume":"11","author":"RJ Young","year":"2010","unstructured":"Young RJ, Brown NJ, Reed MW, Hughes D, Woll PJ. Angiosarcoma. Lancet Oncol. 2010;11:983\u201391. https:\/\/doi.org\/10.1016\/S1470-2045(10)70023-1.","journal-title":"Lancet Oncol"},{"key":"2395_CR3","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.3892\/ol.2015.2919","volume":"9","author":"J Ye","year":"2015","unstructured":"Ye J, Li X-F, Wang Y-D, Yuan Y. Long-term survival of a patient with scalp angiosarcoma and multiple metastases treated using combination therapy: a case report. Oncol Lett. 2015;9:1725\u20138. https:\/\/doi.org\/10.3892\/ol.2015.2919.","journal-title":"Oncol Lett"},{"key":"2395_CR4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/COC.0b013e31827e4e7b","volume":"37","author":"D Buehler","year":"2014","unstructured":"Buehler D, Rice SR, Moody JS, Rush P, Hafez G-R, Attia S, et al. Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol. 2014;37:473\u20139. https:\/\/doi.org\/10.1097\/COC.0b013e31827e4e7b.","journal-title":"Am J Clin Oncol"},{"key":"2395_CR5","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1002\/cncr.24462","volume":"115","author":"CM Mery","year":"2009","unstructured":"Mery CM, George S, Bertagnolli MM, Raut CP. Secondary sarcomas after radiotherapy for breast cancer. Cancer. 2009;115:4055\u201363. https:\/\/doi.org\/10.1002\/cncr.24462.","journal-title":"Cancer."},{"key":"2395_CR6","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z","volume":"77","author":"RJ Mark","year":"1996","unstructured":"Mark RJ, Poen JC, Tran LM, Fu YS, Juillard GF. Angiosarcoma: a report of 67 patients and a review of the literature. Cancer. 1996;77:2400\u20136. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19960601)77:11<2400::AID-CNCR32>3.0.CO;2-Z.","journal-title":"Cancer."},{"key":"2395_CR7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3109\/07357900009012210","volume":"18","author":"DM Vail","year":"2000","unstructured":"Vail DM, MacEwen EG. Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Investig. 2000;18:781\u201392 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11107448. Accessed 17 Apr 2019.","journal-title":"Cancer Investig"},{"key":"2395_CR8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2460\/javma.247.4.393","volume":"247","author":"KM Wendelburg","year":"2015","unstructured":"Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001\u20132012). J Am Vet Med Assoc. 2015;247:393\u2013403. https:\/\/doi.org\/10.2460\/javma.247.4.393.","journal-title":"J Am Vet Med Assoc"},{"key":"2395_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1939-1676.1993.tb01033.x","volume":"7","author":"KU Sorenmo","year":"1993","unstructured":"Sorenmo KU, Jeglum KA, Helfand SC. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide. J Vet Intern Med. 1993;7:370\u20136. https:\/\/doi.org\/10.1111\/j.1939-1676.1993.tb01033.x.","journal-title":"J Vet Intern Med"},{"key":"2395_CR10","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/1040638712447580","volume":"24","author":"PA Cole","year":"2012","unstructured":"Cole PA. Association of canine splenic hemangiosarcomas and hematomas with nodular lymphoid hyperplasia or siderotic nodules. J Vet Diagnostic Investig. 2012;24:759\u201362. https:\/\/doi.org\/10.1177\/1040638712447580.","journal-title":"J Vet Diagnostic Investig"},{"key":"2395_CR11","doi-asserted-by":"publisher","first-page":"e0192578","DOI":"10.1371\/journal.pone.0192578","volume":"13","author":"MS Kent","year":"2018","unstructured":"Kent MS, Burton JH, Dank G, Bannasch DL, Rebhun RB. Association of cancer-related mortality, age and gonadectomy in golden retriever dogs at a veterinary academic center (1989-2016). PLoS One. 2018;13:e0192578. https:\/\/doi.org\/10.1371\/journal.pone.0192578.","journal-title":"PLoS One"},{"key":"2395_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1004922","volume":"11","author":"N Tonomura","year":"2015","unstructured":"Tonomura N, Elvers I, Thomas R, Megquier K, Turner-Maier J, Howald C, et al. Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers. PLoS Genet. 2015;11:1\u201324.","journal-title":"PLoS Genet"},{"key":"2395_CR13","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10577-014-9406-z","volume":"22","author":"R Thomas","year":"2014","unstructured":"Thomas R, Borst L, Rotroff D, Motsinger-Reif A, Lindblad-Toh K, Modiano JF, et al. Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma. Chromosom Res. 2014;22:305\u201319. https:\/\/doi.org\/10.1007\/s10577-014-9406-z.","journal-title":"Chromosom Res"},{"key":"2395_CR14","doi-asserted-by":"publisher","first-page":"e0188667","DOI":"10.1371\/journal.pone.0188667","volume":"12","author":"G Wang","year":"2017","unstructured":"Wang G, Wu M, Maloneyhuss MA, Wojcik J, Durham AC, Mason NJ, et al. Actionable mutations in canine hemangiosarcoma. PLoS One. 2017;12:e0188667. https:\/\/doi.org\/10.1371\/journal.pone.0188667.","journal-title":"PLoS One"},{"key":"2395_CR15","doi-asserted-by":"publisher","unstructured":"Megquier K, Turner-Maier J, Swofford R, Kim J-H, Sarver AL, Wang C, et al. Comparative genomics reveals shared mutational landscape in canine hemangiosarcoma and human angiosarcoma. Mol Cancer Res. 2019. https:\/\/doi.org\/10.1158\/1541-7786.MCR-19-0221.","DOI":"10.1158\/1541-7786.MCR-19-0221"},{"key":"2395_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/1471-2407-10-619","volume":"10","author":"BA Tamburini","year":"2010","unstructured":"Tamburini BA, Phang TL, Fosmire SP, Scott MC, Trapp SC, Duckett MM, et al. Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma. BMC Cancer. 2010;10:619. https:\/\/doi.org\/10.1186\/1471-2407-10-619.","journal-title":"BMC Cancer"},{"key":"2395_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ajpath.2013.12.025","volume":"184","author":"BH Gorden","year":"2014","unstructured":"Gorden BH, Kim J-H, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, et al. Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol. 2014;184:985\u201395. https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.025.","journal-title":"Am J Pathol"},{"key":"2395_CR18","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nprot.2016.086","volume":"11","author":"DB Mahat","year":"2016","unstructured":"Mahat DB, Kwak H, Booth GT, Jonkers IH, Danko CG, Patel RK, et al. Base-pair-resolution genome-wide mapping of active RNA polymerases using precision nuclear run-on (PRO-seq). Nat Protoc. 2016;11:1455.","journal-title":"Nat Protoc"},{"key":"2395_CR19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41588-018-0244-3","volume":"50","author":"T Chu","year":"2018","unstructured":"Chu T, Rice EJ, Booth GT, Salamanca HH, Wang Z, Core LJ, et al. Chromatin run-on and sequencing maps the transcriptional regulatory landscape of glioblastoma multiforme. Nat Genet. 2018;50:1553\u201364. https:\/\/doi.org\/10.1038\/s41588-018-0244-3.","journal-title":"Nat Genet"},{"key":"2395_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/ijc.29464","volume":"137","author":"S Neri","year":"2015","unstructured":"Neri S, Ishii G, Hashimoto H, Kuwata T, Nagai K, Date H, et al. Podoplanin-expressing cancer-associated fibroblasts lead and enhance the local invasion of cancer cells in lung adenocarcinoma. Int J Cancer. 2015;137:784\u201396. https:\/\/doi.org\/10.1002\/ijc.29464.","journal-title":"Int J Cancer"},{"key":"2395_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fimmu.2012.00283","volume":"3","author":"JL Astarita","year":"2012","unstructured":"Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283. https:\/\/doi.org\/10.3389\/fimmu.2012.00283.","journal-title":"Front Immunol"},{"key":"2395_CR22","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1038\/s41598-017-04324-1","volume":"7","author":"K Miyata","year":"2017","unstructured":"Miyata K, Takemoto A, Okumura S, Nishio M, Fujita N. Podoplanin enhances lung cancer cell growth in vivo by inducing platelet aggregation. Sci Rep. 2017;7:4059. https:\/\/doi.org\/10.1038\/s41598-017-04324-1.","journal-title":"Sci Rep"},{"key":"2395_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2016.12.009","volume":"57\u201358","author":"A Pozzi","year":"2017","unstructured":"Pozzi A, Yurchenco PD, Iozzo RV. The nature and biology of basement membranes. Matrix Biol. 2017;57\u201358:1\u201311. https:\/\/doi.org\/10.1016\/j.matbio.2016.12.009.","journal-title":"Matrix Biol"},{"key":"2395_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.matbio.2014.06.002","volume":"38","author":"T Ishikawa","year":"2014","unstructured":"Ishikawa T, Wondimu Z, Oikawa Y, Gentilcore G, Kiessling R, Egyhazi Brage S, et al. Laminins 411 and 421 differentially promote tumor cell migration via \u03b16\u03b21 integrin and MCAM (CD146). Matrix Biol. 2014;38:69\u201383. https:\/\/doi.org\/10.1016\/j.matbio.2014.06.002.","journal-title":"Matrix Biol"},{"key":"2395_CR25","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1158\/0008-5472.CAN-15-1364","volume":"76","author":"J Wwragg","year":"2016","unstructured":"Wwragg J, Finnity JP, Anderson JA, Ferguson HJM, Porfiri E, Bhatt RI, et al. MCAM and LAMA4 are highly enriched in tumor blood vessels of renal cell carcinoma and predict patient outcome. Cancer Res. 2016;76:2314.","journal-title":"Cancer Res"},{"key":"2395_CR26","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2460\/javma.251.5.559","volume":"251","author":"AS Moore","year":"2017","unstructured":"Moore AS, Rassnick KM, Frimberger AE. Evaluation of clinical and histologic factors associated with survival time in dogs with stage II splenic hemangiosarcoma treated by splenectomy and adjuvant chemotherapy: 30 cases (2011\u20132014). J Am Vet Med Assoc. 2017;251:559\u201365. https:\/\/doi.org\/10.2460\/javma.251.5.559.","journal-title":"J Am Vet Med Assoc"},{"key":"2395_CR27","doi-asserted-by":"publisher","first-page":"8888","DOI":"10.1074\/jbc.M806590200","volume":"284","author":"G Zhang","year":"2009","unstructured":"Zhang G, Chen S, Goldoni S, Calder BW, Simpson HC, Owens RT, et al. Genetic evidence for the coordinated regulation of collagen fibrillogenesis in the cornea by decorin and biglycan. J Biol Chem. 2009;284:8888\u201397. https:\/\/doi.org\/10.1074\/jbc.M806590200.","journal-title":"J Biol Chem"},{"key":"2395_CR28","doi-asserted-by":"publisher","first-page":"49120","DOI":"10.1074\/jbc.M206891200","volume":"277","author":"C Wiberg","year":"2002","unstructured":"Wiberg C, Heineg\u00e5rd D, Wengl\u00e9n C, Timpl R, M\u00f6rgelin M. Biglycan organizes collagen VI into hexagonal-like networks resembling tissue structures. J Biol Chem. 2002;277:49120\u20136. https:\/\/doi.org\/10.1074\/jbc.M206891200.","journal-title":"J Biol Chem"},{"key":"2395_CR29","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1083\/jcb.141.5.1277","volume":"141","author":"S Chakravarti","year":"1998","unstructured":"Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol. 1998;141:1277\u201386 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9606218. Accessed 29 Apr 2019.","journal-title":"J Cell Biol"},{"key":"2395_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2019.01.003","volume":"491","author":"S Appunni","year":"2019","unstructured":"Appunni S, Anand V, Khandelwal M, Gupta N, Rubens M, Sharma A. Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer. Clin Chim Acta. 2019;491:1\u20137. https:\/\/doi.org\/10.1016\/j.cca.2019.01.003.","journal-title":"Clin Chim Acta"},{"key":"2395_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-94-017-9153-3_10","volume-title":"Cellular signaling by collagen-binding Integrins","author":"J Heino","year":"2014","unstructured":"Heino J. Cellular signaling by collagen-binding Integrins. Dordrecht: Springer; 2014. p. 143\u201355. https:\/\/doi.org\/10.1007\/978-94-017-9153-3_10."},{"key":"2395_CR32","doi-asserted-by":"publisher","first-page":"40187","DOI":"10.1074\/jbc.M508226200","volume":"280","author":"SJ Wall","year":"2005","unstructured":"Wall SJ, Werner E, Werb Z, DeClerck YA. Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen. J Biol Chem. 2005;280:40187\u201394. https:\/\/doi.org\/10.1074\/jbc.M508226200.","journal-title":"J Biol Chem"},{"key":"2395_CR33","doi-asserted-by":"publisher","first-page":"6633","DOI":"10.1074\/jbc.M116.770057","volume":"292","author":"I Majkowska","year":"2017","unstructured":"Majkowska I, Shitomi Y, Ito N, Gray NS, Itoh Y. Discoidin domain receptor 2 mediates collagen-induced activation of membrane-type 1 matrix metalloproteinase in human fibroblasts. J Biol Chem. 2017;292:6633\u201343. https:\/\/doi.org\/10.1074\/jbc.M116.770057.","journal-title":"J Biol Chem"},{"issue":"Pt 15","key":"2395_CR34","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1242\/jcs.033001","volume":"121","author":"S Huveneers","year":"2008","unstructured":"Huveneers S, Truong H, F\u00e4ssler R, Sonnenberg A, Danen EHJ. Binding of soluble fibronectin to integrin alpha5 beta1 - link to focal adhesion redistribution and contractile shape. J Cell Sci. 2008;121(Pt 15):2452\u201362. https:\/\/doi.org\/10.1242\/jcs.033001.","journal-title":"J Cell Sci"},{"issue":"Pt 11","key":"2395_CR35","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1242\/jcs.107.11.3153","volume":"107","author":"A T\u00f6zeren","year":"1994","unstructured":"T\u00f6zeren A, Kleinman HK, Wu S, Mercurio AM, Byers SW. Integrin alpha 6 beta 4 mediates dynamic interactions with laminin. J Cell Sci. 1994;107(Pt 11):3153\u201363 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7699012. Accessed 29 Apr 2019.","journal-title":"J Cell Sci"},{"key":"2395_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fcell.2018.00066","volume":"6","author":"Y Qi","year":"2018","unstructured":"Qi Y, Xu R. Roles of PLODs in collagen synthesis and cancer progression. Front Cell Dev Biol. 2018;6:66. https:\/\/doi.org\/10.3389\/fcell.2018.00066.","journal-title":"Front Cell Dev Biol"},{"key":"2395_CR37","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s13277-013-1511-7","volume":"35","author":"M Fang","year":"2014","unstructured":"Fang M, Yuan J, Peng C, Li Y. Collagen as a double-edged sword in tumor progression. Tumour Biol. 2014;35:2871\u201382. https:\/\/doi.org\/10.1007\/s13277-013-1511-7.","journal-title":"Tumour Biol"},{"issue":"Pt 7","key":"2395_CR38","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1242\/jcs.01731","volume":"118","author":"EG Canty","year":"2005","unstructured":"Canty EG, Kadler KE. Procollagen trafficking, processing and fibrillogenesis. J Cell Sci. 2005;118(Pt 7):1341\u201353. https:\/\/doi.org\/10.1242\/jcs.01731.","journal-title":"J Cell Sci"},{"key":"2395_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","volume":"16","author":"R Kelwick","year":"2015","unstructured":"Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family. Genome Biol. 2015;16:113. https:\/\/doi.org\/10.1186\/s13059-015-0676-3.","journal-title":"Genome Biol"},{"key":"2395_CR40","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1242\/jcs.129510","volume":"126","author":"R Albrechtsen","year":"2013","unstructured":"Albrechtsen R, Kveiborg M, Stautz D, Vikes\u00e5 J, Noer JB, Kotzsh A, et al. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth. J Cell Sci. 2013;126:4707\u201320. https:\/\/doi.org\/10.1242\/jcs.129510.","journal-title":"J Cell Sci"},{"key":"2395_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/J.MATBIO.2015.03.005","volume":"44\u201346","author":"V Arpino","year":"2015","unstructured":"Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44\u201346:247\u201354. https:\/\/doi.org\/10.1016\/J.MATBIO.2015.03.005.","journal-title":"Matrix Biol"},{"key":"2395_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","volume":"2010","author":"K Brew","year":"1803","unstructured":"Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 1803;2010:55\u201371. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.01.003.","journal-title":"Biochim Biophys Acta"},{"key":"2395_CR43","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1093\/emboj\/cdg342","volume":"22","author":"V Schacht","year":"2003","unstructured":"Schacht V, Ramirez MI, Hong Y-K, Hirakawa S, Feng D, Harvey N, et al. T1 \/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J. 2003;22:3546\u201356. https:\/\/doi.org\/10.1093\/emboj\/cdg342.","journal-title":"EMBO J"},{"key":"2395_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0012-1606(02)00098-2","volume":"256","author":"MI Ramirez","year":"2003","unstructured":"Ramirez MI, Millien G, Hinds A, Cao Y, Seldin DC, Williams MC. T1alpha, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev Biol. 2003;256:61\u201372 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12654292. Accessed 30 Apr 2019.","journal-title":"Dev Biol"},{"key":"2395_CR45","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/dvdy.21463","volume":"237","author":"EAF Mahtab","year":"2008","unstructured":"Mahtab EAF, Wijffels MCEF, Van Den Akker NMS, Hahurij ND, Lie-Venema H, Wisse LJ, et al. Cardiac malformations and myocardial abnormalities inpodoplanin knockout mouse embryos: correlation with abnormal epicardial development. Dev Dyn. 2008;237:847\u201357. https:\/\/doi.org\/10.1002\/dvdy.21463.","journal-title":"Dev Dyn"},{"key":"2395_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/jb\/mvs108","volume":"152","author":"N Fujita","year":"2012","unstructured":"Fujita N, Takagi S. The impact of Aggrus\/podoplanin on platelet aggregation and tumour metastasis. J Biochem. 2012;152:407.","journal-title":"J Biochem"},{"key":"2395_CR47","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/mab.2016.0040","volume":"35","author":"S Ogasawara","year":"2016","unstructured":"Ogasawara S, Honma R, Kaneko MK, Fujii Y, Kagawa Y, Konnai S, et al. Podoplanin expression in canine melanoma. Monoclon Antib Immunodiagn Immunother. 2016;35:304\u20136.","journal-title":"Monoclon Antib Immunodiagn Immunother"},{"key":"2395_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbrep.2018.11.005","volume":"17","author":"Y Kato","year":"2019","unstructured":"Kato Y, Ohishi T, Kawada M, Maekawa N, Konnai S, Itai S, et al. The mouse\u2013canine chimeric anti-dog podoplanin antibody P38B exerts antitumor activity in mouse xenograft models. Biochem Biophys Reports. 2019;17:23\u20136.","journal-title":"Biochem Biophys Reports"},{"key":"2395_CR49","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1182\/blood-2010-04-278564","volume":"116","author":"LN Cueni","year":"2010","unstructured":"Cueni LN, Chen L, Zhang H, Marino D, Huggenberger R, Alitalo A, et al. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin. Blood. 2010;116:4376.","journal-title":"Blood"},{"key":"2395_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1939-1676.1991.tb00923.x","volume":"5","author":"AS Hammer","year":"1991","unstructured":"Hammer AS, Couto CG, Swardson C, Getzy D. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med. 1991;5:11.","journal-title":"J Vet Intern Med"},{"key":"2395_CR51","first-page":"985","volume":"2","author":"NM Khazenzon","year":"2003","unstructured":"Khazenzon NM, Ljubimov AV, Lakhter AJ, Fujita M, Fujiwara H, Sekiguchi K, et al. Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Mol Cancer Ther. 2003;2:985\u201394 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14578463. Accessed 4 Apr 2019.","journal-title":"Mol Cancer Ther"},{"key":"2395_CR52","doi-asserted-by":"publisher","first-page":"e0194023","DOI":"10.1371\/journal.pone.0194023","volume":"13","author":"S Horibata","year":"2018","unstructured":"Horibata S, Rice EJ, Mukai C, Marks BA, Sams K, Zheng H, et al. ER-positive breast cancer cells are poised for RET-mediated endocrine resistance. PLoS One. 2018;13:e0194023.","journal-title":"PLoS One"},{"key":"2395_CR53","volume-title":"Quality control tool for high throughput sequence data","author":"S Andrews","year":"2010","unstructured":"Andrews S. FastQC A Quality control tool for high throughput sequence data. 2010. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. Accessed 29 Mar 2019."},{"key":"2395_CR54","doi-asserted-by":"publisher","unstructured":"Chu T, Wang Z, Chou S-P, Danko CG. Discovering transcriptional regulatory elements from run-on and sequencing data using the web-based dREG gateway. Curr Protoc Bioinforma. 2018:e70. https:\/\/doi.org\/10.1002\/cpbi.70.","DOI":"10.1002\/cpbi.70"},{"key":"2395_CR55","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"2395_CR56","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"Database issue","key":"2395_CR57","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/NAR\/GKY1038","volume":"47","author":"H Mi","year":"2019","unstructured":"Mi H, Muruganujan A, Ebert D, Huang X, Thomas PD. PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools. Nucleic Acids Res. 2019;47(Database issue):D419. https:\/\/doi.org\/10.1093\/NAR\/GKY1038.","journal-title":"Nucleic Acids Res"},{"key":"2395_CR58","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1089\/mab.2016.0022","volume":"35","author":"R Honma","year":"2016","unstructured":"Honma R, Kaneko MK, Ogasawara S, Fujii Y, Konnai S, Takagi M, et al. Specific detection of dog podoplanin expressed in renal glomerulus by a novel monoclonal antibody PMab-38 in immunohistochemistry. Monoclon Antib Immunodiagn Immunother. 2016;35:212\u20136. https:\/\/doi.org\/10.1089\/mab.2016.0022.","journal-title":"Monoclon Antib Immunodiagn Immunother."},{"key":"2395_CR59","doi-asserted-by":"publisher","first-page":"e11768","DOI":"10.1371\/journal.pone.0011768","volume":"5","author":"BD Cherrington","year":"2010","unstructured":"Cherrington BD, Morency E, Struble AM, Coonrod SA, Wakshlag JJ. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones. PLoS One. 2010;5:e11768. https:\/\/doi.org\/10.1371\/journal.pone.0011768.","journal-title":"PLoS One"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-020-02395-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-020-02395-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T19:10:06Z","timestamp":1624302606000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-020-02395-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1186\/s12917-020-02395-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.20379\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.20379\/v1","asserted-by":"object"}]},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. All samples in this study were purchased from the Canine Comparative Oncology & Genomics Consortium and Cornell Veterinary Biobank.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"206"}}